Corcept Therapeutics Inc Earnings

Corcept Therapeutics Inc’s revenue jumped 13.75% since last year same period to $207.64Mn in the Q3 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated 6.79% jump in its revenue since last 3-months.

Corcept Therapeutics Inc’s net profit fell -58.54% since last year same period to $19.36Mn in the Q3 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -44.92% fall in its net profits since last 3-months.

Corcept Therapeutics Inc’s net profit margin fell -63.55% since last year same period to 9.32% in the Q3 2025. On a quarterly growth basis, Corcept Therapeutics Inc has generated -48.43% fall in its net profit margins since last 3-months.

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.17 - a -10.46% fall from last quarter’s estimates.

Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.17.

Corcept Therapeutics Inc’s earning per share (EPS) fell -100% since last year same period to 0 in the Q3 2025. This indicates that the Corcept Therapeutics Inc has generated -100% annual rate of fall in its earning per share (EPS) in the last 4 quarters.